CFO
ABEV icon

Callan Family Office’s Ambev ABEV Stock Holding History

Callan Family Office’s Portfolio ABEV Stock Details ABEV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.44M Buy
776,029
+41,827
+6% +$131K 0.05% 337
2026
Q1 		$2.14M Buy
734,202
+45,823
+7% +$131K 0.05% 337
2025
Q4 		$1.7M Buy
688,379
+557,946
+428% +$1.33M 0.04% 393
2025
Q3 		$291K Sell
130,433
-86,068
-40% -$197K 0.01% 718
2025
Q2 		$522K Buy
216,501
+130,867
+153% +$318K 0.02% 569
2025
Q1 		$200K Sell
85,634
-65,272
-43% -$131K 0.02% 530
2024
Q4 		$279K Buy
+150,906
New +$334K 0.02% 498

Other funds holding ABEV

First Eagle Investment Management
First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return
GQG Partners
GQG Partners Ft. Lauderdale, Florida $53.8B AUM 19.23% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
SCP
Seafarer Capital Partners Larkspur, California $434M AUM 22.8% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM
BIP
Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return
ETC
Exchange Traded Concepts Oklahoma City, Oklahoma $21.9B AUM 68.6% 1-Year Est. Return

Callan Family Office's ABEV Position: Q2 2026 in Review

Callan Family Office increased its Ambev (ABEV) stake by 5.7% in Q2 2026, buying an estimated $131K and bringing the position to 776,029 shares worth $2.44M. The position accounts for 0.05% of the portfolio, ranked #337.

Callan Family Office first reported a position in ABEV in Q4 2024 and has held it in 7 quarters since. 403 funds tracked by Wall St. Rank hold ABEV as of Q2 2026.

  • Callan Family Office held 776,029 shares of Ambev worth $2.44M as of Q2 2026.
  • Callan Family Office bought 41,827 Ambev shares in Q2 2026, an estimated $131K.
  • Ambev made up 0.05% of Callan Family Office's portfolio in Q2 2026, its #337 holding.
  • Callan Family Office first reported a position in Ambev in Q4 2024 and has held it in 7 quarters since.
  • 403 funds tracked by Wall St. Rank held Ambev as of Q2 2026.

Based on Callan Family Office's 13F filing for Q2 2026, filed 11 Aug 2026.